Delivery Order SPE2DB24D1007-SPE2DB25FBZBW

Award Date 10/25/24
Potential Completion Date 10/28/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $26,561.87 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,560,842,890 units of the prescription drug Carvedilol ER 20 mg capsules. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a prime vehicle for providing a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Carvedilol ER 20 mg capsules. The firm-fixed-price contract, valued at $3,154.94, has an ultimate completion date of July 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a $2,232.12 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 20 mg capsules. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of Carvedilol ER 20 mg capsules. The contract has a ceiling value of $1,200.47 and an ultimate completion date of April 3, 2024. This order is placed against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 through December 31, 2025. The IDC...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of 4,565,800 units of the prescription drug Carvedilol ER 10 mg capsules. The contract has a total ceiling value of $20,952.58 and an ultimate completion date of September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,134,894 units of the medication Carvedilol ER 20 mg capsules. The contract, valued at $24,534.64, is a firm fixed-price delivery order with an ultimate completion date of October 18, 2024. AmerisourceBergen Drug Corp is the prime contractor for this award, and there is no indication of any set-aside requirements. The contract...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4566599978 units of the drug carvedilol ER 20 mg capsules. The $21,226.09 firm fixed-price contract was awarded on December 3, 2024 by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 4, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,154.10, is for the delivery of 4,567,925,429 units of the medication Carvedilol ER 20 mg capsules. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,013,166 units of the prescription drug Carvedilol ER 20 mg capsules, with a ceiling value of $2,913.34. The award date is April 23, 2025, and the ultimate completion date is April 24, 2025. This contract is not a set-aside and represents open competition....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,171,126 units of the prescription medication Carvedilol ER 20 mg capsules in 30-count packages, with a ceiling value of $1,583.00. The contract has an ultimate completion date of May 8, 2025 and was awarded on May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB25FBZBW
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,210 units of the medication Carvedilol ER 20 mg capsules. The contract has a ceiling value of $2,769.87 and a period of performance through October 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a small business set-aside designation, indicating open competition.

Generated 1/24/25, 9:10 AM